New strategy to attack aggressive brain cancer shows promise
Time:2024-05-21 12:26:21 Source:opinionsViews(143)
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Previous:Hollywood star Shia LaBeouf is spotted on the streets of Gavin and Stacey's hometown Barry
Next:Who is Jacob Zuma, the former South African president disqualified from next week's election?
You may also like
- California congressman urges closer consultation with tribes on offshore wind
- Yankees get career
- Tommy Paul feels right at home on European clay. Swiatek to play Sabalenka in Italian Open final
- Nevada Supreme Court denies appeal from Washoe County election
- Shohei Ohtani's first walk
- UNC interim chancellor backs AD Bubba Cunningham after trustee criticism, audit push
- Irish interest in NFL heats up as league scouts more international cities to stage games
- Queen's Club to stage women's event next year in run
- Dodgers acquire pitcher Yohan Ramírez from Mets for cash